RETN and colorectal carcinoma: Case–control studies, in which resistin concentrations were measured after CRC cancer diagnosis, reported higher resistin concentrations in CRC patients as compared to controls (Nakajima et al. 2010; Danese et al. 2012) which may be due to inflammation in the presence of the existing CRC tumors.